Case Report
In this article, the authors describe a case study of a 31-year-old woman known to have multiple sclerosis and concomitant severe central sleep apnoea (CSA). She received the medication dimethyl fumarate for the treatment of multiple sclerosis, and her CSA significantly improved to mild CSA after the treatment.
Review
The authors provide a comprehensive overview of clinicians’ adherence to heart failure guidelines in a specialized real-life setting, particularly regarding use and optimization of guideline-derived medical therapies, as well as the implementation of more recent agents. They seek potential explanations for suboptimal treatment and its impact on patient outcomes.
Corrigendum
The authors wish to make the following corrections to their article: Yang X, Lohsiriwat V, Chang FCS, Chye TT, Howard CJ, Qiao L, Shaw SW, Tran TNA, Yung C, Dellosa D, Nagrale D. Real-world management of abnormal scarring using topical silicone gel: expert consensus and case series from the Asian SCARS Expert Group. Drugs Context. 2023;12:2023-4-3. https://doi.org/10.7573/dic.2023-4-3
Review
The purpose of this review is to discuss resistance mechanisms and challenges with currently available agents, provide evidence for combination therapy, and evaluate the newly available and upcoming antifungal agents and their proposed place in the treatment of challenging fungal infections.
Original Research
This article aims to evaluate and compare the effects of xyloglucan–gelatin and xyloglucan–gelose associations on E. coli LPS-induced enteritis using a rat model of intestinal hyperpermeability and mucosal inflammation.
